Department of Microbiology and Immunology, McGill University , Montreal, QC, Canada.
Department of Pharmacology and Physiology, Department of Neuroscience, GRSNC, Université de Montréal , Montreal, QC, Canada.
Gut Microbes. 2020 Nov 9;12(1):1-11. doi: 10.1080/19490976.2020.1830694.
Parkinson's disease (PD) is a neurodegenerative disorder that has been shown to be influenced by the intestinal milieu. The gut microbiota is altered in PD patients, and murine studies have begun suggesting a causative role for the gut microbiota in progression of PD. We have previously shown that repeated infection with the intestinal murine pathogen resulted in the development of PD-like pathology in mice compared to wild-type littermates. This addendum aims to expand this work by characterizing the gut microbiota during infection in our PD model. We observed little disturbance to the fecal microbiota diversity both between infection timepoints and between and wild-type control littermates. However, the level of short-chain fatty acids appeared to be altered over the course of infection with butyric acid significantly increasing in mice and isobutyric acid increasing in wild-type mice.
帕金森病(PD)是一种神经退行性疾病,已有研究表明其受到肠道环境的影响。PD 患者的肠道微生物群发生改变,并且鼠类研究开始提示肠道微生物群在 PD 进展中起因果作用。我们之前的研究表明,反复感染肠道鼠病原体 会导致 小鼠出现类似 PD 的病理学改变,而与野生型同窝仔相比。本附录旨在通过对我们的 PD 模型中 感染期间的肠道微生物群进行特征描述来扩展这项工作。我们观察到,在感染时间点之间以及 与野生型对照同窝仔之间,粪便微生物群多样性几乎没有受到干扰。然而,在感染过程中短链脂肪酸的水平似乎发生了变化,其中 小鼠中的丁酸显著增加,而野生型小鼠中的异丁酸增加。